Overview
iPATH Solutions helps ensure patients with unmet medical needs access innovative therapeutic and preventative options. The company develops market access and pricing strategies for innovative assets, provides commercial launch execution, and collaborates with stakeholders to shape sustainable solutions for patient access to healthcare.
In the news
- When should companies start preparing for an EU Joint Clinical Assessment (JCA)?" - Based on the first completed JCA experiences, the answer is clear: much earlier than many organizations might expect.
- The first EU joint clinical assessment (JCA) report is out … so what does it teach us?
Related profiles
Something wrong or missing? Send an update. Fixed within 24 hours.